BSECompany Update7 Oct 2026 · 7 Oct 2026, 05:16 pm

We would like to inform that the Company has acquired 9.21% stake in Torrent Urja 19 Private Limited.

Alivus Life Sciences Ltd · 543322

✦ AI SummaryExpansion

Alivus Life Sciences Ltd has acquired a 9.21% stake in Torrent Urja 19 Private Limited, a special purpose vehicle for setting up solar or other renewable energy projects, to comply with regulatory requirements for being a captive user under Indian electricity laws.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alivus Life Sciences Ltd - 543322 - Announcement Under Regulation 30 Of SEBI (LODR), 2015 - Acquisition.

Attachments (1)

📄

8f5ea53f-6999-4dd4-a340-ab465824c4ab.pdf

pdf

Download →
View document text
October 7, 2026 To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS Dear Sir, Sub: Update on acquisition of securities of Torrent Urja 19 Private Limited This is in reference to our prior intimation dated April 2, 2025, regarding entering into Share Purchase cum Subscription Shareholders’ Agreement and Power Supply Agreement with Torrent Urja 19 Private Limited (SPV). In this regard, we write to inform that the Company has acquired a 9.21% stake in the said SPV, according to the terms and conditions of the above referenced Share Purchase cum Subscription Shareholders’ Agreement. Requisite disclosure required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with relevant circulars issued thereunder, is enclosed herewith as Annexure-A. Request you to kindly take the same on record. Thanking you, Your Sincerely, For Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Rudalf Corriea Company Secretary & Compliance officer Encl: as above Alivus Life Sciences Limited ( formerly Glenmark Life Sciences Limited ) Corporate Office: Registered Office: Technopolis Knowledge Park, A wing, 4th Floor M, ahakali Plot No 170-172, Chandramouli Industrial Estate Caves Road, Andheri East, Mumba–i 400093, India Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com Annexure A Disclosures/ Details of Agreement pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and relevant circulars issued thereunder Sr. Particulars Details 1 Name of the target entity, details Name of the target entity: in brief such as size, turnover etc.; Torrent Urja 19 Private Limited Brief Details: Torrent Urja 19 Private Limited, a subsidiary of Torrent Green Energy Private Limited, is a special purpose vehicle formed for purpose of setting up solar or other renewable energy projects. History of last 3 years turnover: Nil as of 31st March 2026. 2 Whether the acquisition would fall Acquisition doesn’t fall within the purview of within related party transaction(s) related party transactions. and whether the promoter/ promoter group/ group The promoter of the Company, Nirma Limited companies have any interest in has also entered into a similar Power Supply the entity being acquired? If yes, Agreement and Share Purchase cum nature of interest and details Subscription Shareholders Agreement with thereof and whether the same is Torrent Urja 19 Private Limited whereby done at “arm’s length”; Nirma Limited has acquired 16.99% stake in Torrent Urja 19 Private Limited. 3 Industry to which the entity being Generation and transmission of solar energy acquired belongs; and other sources of renewable energy. 4 Objects and impact of acquisition In line with Alivus Life Sciences Limited’s (including but not limited to, (formerly Glenmark Life Sciences Limited) disclosure of reasons for commitment to become carbon neutral by acquisition of target entity, if its 2030, this investment will enhance the share of business is outside the main line of renewable power in its operation. The business of the listed entity) acquisition of shares will enable Alivus Life Sciences Limited (“Alivus”) to invest in renewable energy and thereby comply with regulatory requirement for being a captive user under Indian electricity laws. Alivus has acquired 9.21% stake in Torrent Urja 19 Private Limited in order to qualify for captive requirements as per the provision of Electricity Act, 2003. 5 Brief details of any governmental Not applicable or regulatory approvals required for the acquisition; 6 Indicative time period for The Company will invest up to an amount not completion of the acquisition; exceeding Rs. 16 Crores by way of investment through Equity. Out of this amount, Rs. 14.04 Crores has been invested in this transaction resulting in the Company subscribing to 9.21% equity shares. 7 Consideration - whether cash Cash Consideration consideration or share swap or any other form and details of the same; 8 Cost of acquisition and/ or the The Company has presently invested Rs. 14.04 price at which the shares are crores, equivalent to 9.21% in the equity share acquired; capital of the SPV. 9 Percentage of shareholding / The percentage of shareholding in the SPV is control acquired and / or number 9.21% of the paid up equity share capital of the of shares acquired SPV. 10 Brief background about the Brief background of the target entity: entity acquired in terms of Torrent Urja 19 Private Limited was products/line of business incorporated on 6 August 2024 in India and is acquired, date of incorporation, engaged in business of generating, producing, history of last 3 years turnover, accumulating, storing, improving, buying, country in which the acquired selling, reselling, transmitting, distributing and entity has presence and any other supplying electrical power generated using significant information (in brief) solar energy and all other sources of renewable energy and developing infrastructure projects based on non-conventional renewable sources of energy in both grid – connected as well as off-grid mode (distributed generation) and/ or related assets or products or activities like Non-conventional Energy generation and transmission and to act as agent, representative, consultant, collaborator or otherwise to deal in electrical power. History of last 3 years turnover: NIL Country: India